Global Regulation of Corporate Conduct: Effective Pursuit of a Slave-Free Supply Chain
68 Am. U. L. Rev. 1821 (2019).
The New Social Contracts in International Supply Chains
68 Am. U. L. Rev. 1869 (2019).
Ships in the Night: Resolving Administrative Conflict Between FDA- and Patent-Related Legislation
68 Am. U. L. Rev. 1111 (2019).
Institutional Design for Innovation: A Radical Proposal for Addressing § 101 Patent-Eligible Subject Matter
68 Am. U. L. Rev. 1191 (2019).
The Dark Data Quandary
68 Am. U. L. Rev. 761 (2019).
The Surprising Reach of FDA Regulation of Cannabis, Even After Descheduling
68 Am. U. L. Rev. 823 (2019).
An Error and an Evil: The Strange History of Implied Commerce Powers
68 Am. U. L. Rev. 927 (2019).
Reform of Section 355
68 Am. U. L. Rev. 447 (2018).
Beyond Balancing: Rethinking the Law of Embryo Disposition
68 Am. U. L. Rev. 515 (2018).
Crypto Securities: On the Risks of Investments in Blockchained-Based Assets and the Dilemmas of Securities Regulation
68 Am. U. L. Rev.A 69 (2018).
